We are live on ! Find out more
WP

Woodline Partners Portfolio holdings

AUM $26.4B
1-Year Est. Return 44.85%
This Fund
S&P 500
This Quarter Est. Return
+2.52%
1 Year Est. Return
+44.85%
3 Year Est. Return
+131.23%
5 Year Est. Return
+174.12%
10 Year Est. Return
AUM
$7.16B
AUM Growth
+$666M
Cap. Flow
+$831M
Cap. Flow %
11.61%
Top 10 Hldgs %
17.05%
Holding
983
New
189
Increased
207
Reduced
145
Closed
240

Top Sells

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$73.2M
2
PANW icon
Palo Alto Networks
PANW
+$59.8M
3
ALKS icon
Alkermes
ALKS
+$55.3M
4
ACN icon
Accenture
ACN
+$53.8M
5
JNJ icon
Johnson & Johnson
JNJ
+$53M

Sector Composition

Rank Sector Weight
1 Healthcare 36.05%
2 Technology 29.2%
3 Financials 8.76%
4 Industrials 7.7%
5 Communication Services 4.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AUPH icon
751
Aurinia Pharmaceuticals
AUPH
$2.07B
-169,209
Closed -$1.7M
AVTR icon
752
Avantor
AVTR
$8.91B
-1,226,844
Closed -$38.2M
AXON
753
Axon Enterprise
AXON
$42.1B
-4,328
Closed -$403K
BAND
754
Bandwidth Inc
BAND
$1.44B
-18,265
Closed -$344K
BILL icon
755
BILL Holdings
BILL
$4.68B
-78,677
Closed -$8.65M
CACI icon
756
CACI
CACI
$13.9B
-109,628
Closed -$30.9M
CASY icon
757
Casey's General Stores
CASY
$30.8B
-33,791
Closed -$6.25M
CELH icon
758
Celsius Holdings
CELH
$6.08B
-244,482
Closed -$5.32M
CGEM icon
759
Cullinan Oncology
CGEM
$1.1B
-818,572
Closed -$10.5M
CHE icon
760
Chemed
CHE
$7.18B
-1,020
Closed -$479K
CHKP icon
761
Check Point Software Technologies
CHKP
$12.8B
-141,366
Closed -$17.2M
CHTR icon
762
Charter Communications
CHTR
$18.8B
-45,583
Closed -$21.4M
CLDX icon
763
Celldex Therapeutics
CLDX
$3.26B
-64,454
Closed -$1.74M
CNC icon
764
Centene
CNC
$31.7B
-216,228
Closed -$18.3M
COCHW icon
765
Envoy Medical Warrant
COCHW
-224,999
Closed -$22K
CRBU icon
766
Caribou Biosciences
CRBU
$163M
-68,802
Closed -$374K
CXM icon
767
Sprinklr
CXM
$1.55B
-17,394
Closed -$176K
DAWN
768
DELISTED
Day One Biopharmaceuticals
DAWN
-150,176
Closed -$2.69M
DDOG icon
769
Datadog
DDOG
$81.6B
-68,689
Closed -$6.54M
DT icon
770
Dynatrace
DT
$14.2B
-844,775
Closed -$33.3M
DYN icon
771
Dyne Therapeutics
DYN
$4.83B
-666,997
Closed -$4.58M
EDIT icon
772
Editas Medicine
EDIT
$445M
-1,016,891
Closed -$12M
ELV icon
773
Elevance Health
ELV
$84.9B
-29,410
Closed -$14.2M
ERAS icon
774
Erasca
ERAS
$6.34B
-362,146
Closed -$2.02M
ETWO
775
DELISTED
E2open Parent Holdings
ETWO
-27,001
Closed -$210K

Similar funds

Woodline Partners's Q3 2022 Portfolio in Review

As of Q3 2022, Woodline Partners held 983 positions worth $7.16B, up 10% from $6.49B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Woodline Partners deployed $831M of net new capital in Q3 2022, opening 189 new positions and adding to 207 existing holdings. Its largest new stake was Amazon: 683,398 shares worth $77.2M.

By sector, the portfolio is most concentrated in Healthcare at 36% of assets, up from 35% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Eli Lilly, an estimated $73.2M trimmed.

  • Woodline Partners's largest Q3 2022 buy was Amazon: 683,398 shares worth $77.2M.
  • Woodline Partners added most to Horizon Therapeutics Public Limited Company Ordinary Shares in Q3 2022, an estimated $146M increase.
  • Woodline Partners's biggest Q3 2022 reduction was Eli Lilly, cutting an estimated $73.2M.
  • Woodline Partners fully exited Palo Alto Networks in Q3 2022, selling an estimated $59.8M.
  • Woodline Partners's ten largest holdings make up 17% of its $7.16B portfolio in Q3 2022.
  • Woodline Partners opened 189 new positions and closed 240 in Q3 2022.
  • Woodline Partners's portfolio value rose 10% quarter-over-quarter to $7.16B.

Based on Woodline Partners's 13F filing for Q3 2022, filed 14 Nov 2022.